Wyrick Susan D. 4
4 · Sana Biotechnology, Inc. · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Wyrick Susan D.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2025-12-13+3,400→ 181,663 total - Tax Payment
Common Stock
2025-12-15$5.22/sh−873$4,557→ 180,790 total - Exercise/Conversion
Restricted Stock Units
2025-12-13−3,400→ 0 total→ Common Stock (3,400 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock.
- [F2]The award vested as to 100% of the restricted stock units on December 13, 2025.